1
/
of
1
Elabscience
SKU:PKSR030477
Recombinant 2019-nCoV Spike Protein (RBD-SD1, His Tag)
Recombinant 2019-nCoV Spike Protein (RBD-SD1, His Tag)
Regular price
$253.00 USD
Regular price
Sale price
$253.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant 2019-nCoV Spike Protein (RBD-SD1, His Tag), a cutting-edge product meticulously engineered to cater to the evolving needs of the scientific community. This exceptional protein, derived from the spike protein of the novel coronavirus strain responsible for the 2019 outbreak, offers unparalleled potential for research and development in the field of virology.
Crafted with utmost precision, the Recombinant 2019-nCoV Spike Protein (RBD-SD1, His Tag) showcases a fusion of the receptor-binding domain (RBD) and the subdomain 1 (SD1), fortified with a histidine (His) tag. This strategic combination empowers researchers with a comprehensive tool to delve into the intricate mechanisms of viral entry and host-cell interaction, enabling a deeper understanding of the pathogenesis of the 2019-nCoV strain.
The Recombinant 2019-nCoV Spike Protein (RBD-SD1, His Tag) boasts exceptional purity and stability, ensuring reliable and reproducible results in a wide array of experimental settings. Its high affinity for the angiotensin-converting enzyme 2 (ACE2) receptor, a key player in viral entry, facilitates the investigation of potential therapeutic interventions and the development of effective vaccines.
This product adheres to the highest industry standards, meticulously manufactured under stringent quality control measures. Each batch undergoes rigorous testing to guarantee its authenticity, integrity, and functionality, providing researchers with the utmost confidence in their scientific endeavors.
With its remarkable versatility and scientific significance, the Recombinant 2019-nCoV Spike Protein (RBD-SD1, His Tag) stands as an indispensable asset for virologists, immunologists, and researchers alike. Unlock the potential of this groundbreaking protein and embark on a journey of discovery, unraveling the mysteries of the 2019-nCoV strain and paving the way for innovative solutions in the battle against emerging viral threats.
Crafted with utmost precision, the Recombinant 2019-nCoV Spike Protein (RBD-SD1, His Tag) showcases a fusion of the receptor-binding domain (RBD) and the subdomain 1 (SD1), fortified with a histidine (His) tag. This strategic combination empowers researchers with a comprehensive tool to delve into the intricate mechanisms of viral entry and host-cell interaction, enabling a deeper understanding of the pathogenesis of the 2019-nCoV strain.
The Recombinant 2019-nCoV Spike Protein (RBD-SD1, His Tag) boasts exceptional purity and stability, ensuring reliable and reproducible results in a wide array of experimental settings. Its high affinity for the angiotensin-converting enzyme 2 (ACE2) receptor, a key player in viral entry, facilitates the investigation of potential therapeutic interventions and the development of effective vaccines.
This product adheres to the highest industry standards, meticulously manufactured under stringent quality control measures. Each batch undergoes rigorous testing to guarantee its authenticity, integrity, and functionality, providing researchers with the utmost confidence in their scientific endeavors.
With its remarkable versatility and scientific significance, the Recombinant 2019-nCoV Spike Protein (RBD-SD1, His Tag) stands as an indispensable asset for virologists, immunologists, and researchers alike. Unlock the potential of this groundbreaking protein and embark on a journey of discovery, unraveling the mysteries of the 2019-nCoV strain and paving the way for innovative solutions in the battle against emerging viral threats.
Share
